fashion -WSS

fashion

author：entertainment 2025-10-02 17:22:06 - browse：95

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Key Senate committee drafts bipartisan bill to stem drug shortages

WSS

Democratic lawmaker calls for 'well

Diversity in clinical trials starts with building trust, experts say

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

More tobacco lobbyists active in statehouses

Bird flu in milk supply is likely coming from asymptomatic cows

Dogs on Prozac: What pet anti

explore

fashion

explore

The cancer drug shortage isn’t new — and neither are the solutions

MultiPlan and major insurers sued for alleged medical price

Activists slam private health insurers over coverage restrictions

NYC plans to house migrants on an island in the East River

Jerome Adams on the need for new antivirals for Covid

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Apple is now the first public company to be valued at $3 trillion

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Novavax promises a turnaround & Lilly roils the obesity market

Diversity in clinical trials starts with building trust, experts say

leisure time

Trump Jan. 6 attorney John Lauro is ex

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Getting Alzheimer's drug Leqembi to patients can be a challenge

Dogs on Prozac: What pet anti

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Why rehabilitation engineers need to center patients in their research

hotspot

focus

entertainment

hotspot